scispace - formally typeset
S

Shaohua Lu

Researcher at Fudan University

Publications -  16
Citations -  532

Shaohua Lu is an academic researcher from Fudan University. The author has contributed to research in topics: Lung cancer & Giardia lamblia. The author has an hindex of 9, co-authored 16 publications receiving 467 citations.

Papers
More filters
Journal ArticleDOI

A plasma microRNA panel for early detection of colorectal cancer

TL;DR: A plasma microRNA panel that has potential clinical value in early CRC detection and would play a critical role on preliminarily screening CRC in general population is revealed.
Journal ArticleDOI

Human miR-1228 as a stable endogenous control for the quantification of circulating microRNAs in cancer patients.

TL;DR: MiR‐1228 is a promising stable endogenous control for quantifying circulating microRNAs in cancer patients and functional network analysis found that “hematological system development” was on the list of the top networks that associate with miR‐ 1228, implying that miR-1228 plays an important role in the hematological system.
Journal ArticleDOI

Two plasma microRNA panels for diagnosis and subtype discrimination of lung cancer.

TL;DR: Two plasma microRNA panels are constructed and validated that have considerable clinical value in diagnosis of lung cancer, and could play an important role in determining optimal treatment strategies based on discrimination between SCLC and NSCLC.
Patent

Compositions and methods for microrna expression profiling of lung cancer

TL;DR: In this paper, a plurality of nucleic acid molecules encoding microRNA sequences are used for identifying one or more mammalian target cells exhibiting or having a predisposition to develop lung cancer.
Journal ArticleDOI

Two MicroRNA Panels to Discriminate Three Subtypes of Lung Carcinoma in Bronchial Brushing Specimens

TL;DR: Two microRNA panels that accurately discriminated between the three subtypes of lung carcinoma in bronchial brushing specimens are found and may have considerable clinical value in differential diagnosis and optimizing treatment strategies based on lung cancer subtypes.